Search results
Pfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoPfizer Inc. (NYSE:PFE) Q1 2024 Earnings Call Transcript May 1, 2024 Pfizer Inc. beats earnings...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 5 days agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
US opens COVID vaccine to little kids, shots begin next week
AOL· 7 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 5 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Increasing the Dose of Smoking Cessation Treatments Improved Abstinence
MedPage Today· 3 days agoAmong participants who were treated with varenicline but were not abstinent, the end-of-treatment...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 5 days agoThis was compared to 67.2% efficacy for RSV and 78.8% efficacy for severe RSV in adults who had...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 6 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for one year, during which ...
The two sides of AstraZeneca’s vaccine ‘miracle’
Daily Telegraph· 6 days agoAstraZeneca had been unable to identify the cause of the clots and the Government bought its Covid vaccines for the next year’s rollout from rivals. In...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 6 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
Regeneron Reverses On Better-Than-Feared Eylea Sales
Investor's Business Daily· 4 days agoHigh-dose Eylea came in at $200 million, beating expectations for $189 million, Leerink Partners analyst David Risinger said in a report. The high dose...